| 8 June 2012 | Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin | Jones, AG; Besser, RE; Shields, BM; et al. |
| 24 March 2017 | A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk | Manning, A; Highland, HM; Gasser, J; et al. |
| 27 December 2019 | De novo mutations in EIF2B1 affecting eIF2 signaling cause neonatal/early onset diabetes and transient hepatic dysfunction | De Franco, E; Caswell, R; Johnson, M; et al. |
| 1 July 2013 | The clinical utility of C-peptide measurement in the care of patients with diabetes | Jones, AG; Hattersley, AT |
| 11 July 2014 | Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability. | Raimondo, A; Chakera, AJ; Thomsen, SK; et al. |
| 1 June 2015 | Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations. | Demirbilek, H; Arya, VB; Ozbek, MN; et al. |
| 14 August 2014 | Neurogenin 3 is important but not essential for pancreatic islet development in humans. | Rubio-Cabezas, O; Codner, E; Flanagan, SE; et al. |
| 6 June 2016 | Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes. | Shepherd, M; Shields, B; Hammersley, S; et al. |
| 17 December 2015 | Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. | Farmer, AJ; Rodgers, LR; Lonergan, M; et al. |
| 17 September 2018 | ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents | Hattersley, AT; Greeley, SAW; Polak, M; et al. |
